Embree Financial Group’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$980K Hold
6,701
0.1% 126
2026
Q1
$838K Hold
6,701
0.1% 124
2025
Q4
$805K Buy
6,701
+42
+0.6% +$5.04K 0.1% 121
2025
Q3
$796K Hold
6,659
0.11% 118
2025
Q2
$753K Hold
6,659
0.11% 111
2025
Q1
$687K Hold
6,659
0.12% 111
2024
Q4
$750K Buy
6,659
+52
+0.8% +$6.11K 0.13% 102
2024
Q3
$757K Hold
6,607
0.13% 94
2024
Q2
$724K Hold
6,607
0.14% 89
2024
Q1
$750K Hold
6,607
0.15% 90
2023
Q4
$649K Buy
+6,607
New +$605K 0.14% 91

Other funds holding IVOG

Embree Financial Group's IVOG Position: Q2 2026 in Review

Embree Financial Group held its Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) position steady in Q2 2026 at 6,701 shares worth $980K. The position accounts for 0.1% of the portfolio, ranked #126.

Embree Financial Group first reported a position in IVOG in Q4 2023 and has held it in 11 quarters since. 81 funds tracked by Wall St. Rank hold IVOG as of Q2 2026.

  • Embree Financial Group held 6,701 shares of Vanguard S&P Mid-Cap 400 Growth ETF worth $980K as of Q2 2026.
  • Embree Financial Group left its Vanguard S&P Mid-Cap 400 Growth ETF share count unchanged in Q2 2026.
  • Vanguard S&P Mid-Cap 400 Growth ETF made up 0.1% of Embree Financial Group's portfolio in Q2 2026, its #126 holding.
  • Embree Financial Group first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2023 and has held it in 11 quarters since.
  • 81 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.